Item 5.07 Submission of Matters to a Vote of Security Holders.

On June 4, 2020, Castle Biosciences, Inc. (the "Company") held its 2020 annual meeting of stockholders (the "Annual Meeting"). At the Annual Meeting, the Company's stockholders voted on the following matters and cast their votes as set forth below:

Proposal 1. Election of Directors

The Company's stockholders elected the three individuals listed below as Class I Directors, each to serve until the Company's 2023 annual meeting of stockholders and until their successors are duly elected and qualified. The final voting results are as follows:



                             For           Withheld        Broker Non-Votes
Joseph C. Cook, III       12,560,193       1,078,445          1,241,382
Miles D. Harrison         13,593,549        45,089            1,241,382
David Kabakoff, Ph.D.     11,947,527       1,691,111          1,241,382

Proposal 2. Ratification of the Selection of Independent Registered Public Accounting Firm

The Company's stockholders ratified the selection of KPMG, LLP by the Audit Committee of the Company's Board of Directors as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2020. The final voting results are as follows:



     For            Against       Abstained
  14,803,181        18,464         58,375

--------------------------------------------------------------------------------




                                       SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has
caused this report to be signed on its behalf by the undersigned hereunto duly
authorized.



                     CASTLE BIOSCIENCES, INC.

                     By:            /s/ Frank Stokes
                                    Frank Stokes
                                    Chief Financial Officer
Date: June 9, 2020

© Edgar Online, source Glimpses